The primary objective was to evaluate the pharmacokinetics, pharmacodynamics, biologic activity, and safety of CC-930.
The primary objective was to evaluate the factors independently associated with antifungal de-escalation.
Our primary objective was to evaluate the long-term subjective and objective outcomes on continence and other urinary symptoms of a trans-obturator mid-urethral sling (TOT) procedure.
The primary objective was to evaluate if physiotherapy plus analgesics, but without benzodiazepines, is equivalent to the same therapy plus benzodiazepines.
The primary objective was to evaluate a theoretically informed media literacy program delivered to a mixed-sex, universal, young adolescent audience.
Our primary objective was to evaluate the applicability and consistency of QUADOMICS.
The primary objective was to evaluate the safety and tolerability of three vaccinations with ADMVA at three different dosage levels in healthy HIV-uninfected adults.
Our primary objective was to evaluate the performance of the OIC-HIV test compared to WB testing as a practical in situ confirmation test.
The primary objective was to evaluate whether oral AC altered the pharmacokinetics of intravenously applied AS and its metabolite dihydroartemisinin (DHA), when given simultaneously or after 1 hour.
The primary objective was to evaluate the safety and reactogenicity of 3 injections of 3 different dose levels of the malaria vaccine FMP2.1/AS02A in malaria-experienced Malian children.
The primary objective was to evaluate the vaccine efficacy (VE) against first clinical episodes of P. falciparum malaria over a six month period commencing 14 days after a third vaccination.
